Hypertension





Clinical Presentation 1


An asymptomatic 10-year-old boy is evaluated for hypertension (HTN) diagnosed during a recent physical examination. He does not remember being told about hypertension in the past, and he has no family history of hypertension. He is not taking any medications.


On physical examination, his blood pressure (BP) is 170/60 mm Hg in both upper extremities. The heart rate is 65/min and regular. Carotid examination is normal; estimated central venous pressure is not elevated. The apical impulse is displaced and sustained. An ejection click is noted at the apex and left sternal border. There is a grade 2/6 early systolic murmur noted at the second right intercostal space. No diastolic murmur is noted over the anterior precordium. Systolic and diastolic murmurs are noted over the patient’s back. There is no bruit noted over the abdomen. The lower extremity pulses are reduced and delayed.


Which of the following is the most likely diagnosis in this patient?




  • A.

    Coarctation of the aorta


  • B.

    Essential HTN


  • C.

    Pheochromocytoma


  • D.

    Renal vascular disease



The correct answer is A


Comment: This patient has classic features of aortic coarctation. He has a pulse delay between the upper and lower extremities (radial artery to femoral artery delay). The BP in the lower extremities, when measured, will be lower than the BP noted in the upper extremities. The patient also has an ejection click and an early systolic murmur consistent with a bicuspid aortic valve, which is present in more than 50% of patients with aortic coarctation. The systolic and diastolic murmurs noted over the back are related to collateral vessels, which also cause the sign of rib notching, seen on this patient’s chest radiograph on the inferior surface of the posterior upper thoracic ribs bilaterally.


Essential HTN is a common cause of systemic HTN, but the physical examination features of this patient are not explained by this diagnosis. In addition, a family history of HTN is common in patients with essential HTN.


Pheochromocytoma causes paroxysmal HTN in about half of affected patients; other pheochromocytomas present similar to patients with essential HTN. The signs and symptoms of pheochromocytoma are variable. The classic triad of sudden severe headaches, diaphoresis, and palpitations carries a high degree of specificity (94%) and sensitivity (91%) for pheochromocytoma in hypertensive patients. The absence of all three symptoms reliably excludes the condition. Finally, the physical examination features in this patient do not reflect this diagnosis.


Renovascular HTN resulting from fibromuscular disease of the renal arteries usually presents in patients younger than 35 years of age. Atherosclerotic renovascular disease is more common in older patients and is frequently associated with vascular disease in other vessels (carotid or coronary arteries and peripheral vessels). Azotemia is often observed in patients with atherosclerotic renovascular HTN. Renal artery stenosis cannot explain this patient’s cardiac and peripheral vascular examination findings.


Clinical Presentation 2


Which nonpharmacological intervention has the greatest approximate impact on systolic BP among patients with HTN?




  • A.

    Following a DASH dietary pattern


  • B.

    Performing aerobic physical activity for 90 to 150 minutes per week


  • C.

    Losing weight to reach an ideal body weight


  • D.

    Reducing intake of dietary sodium



The correct answer is A


Comment: Nonpharmacological interventions are effective in lowering BP and may aid patients with HTN in achieving their target BP. The 2019 American College of Cardiology/American Heart Association Guideline on the Primary Prevention of Cardiovascular Disease Studies suggests that the DASH diet had the greatest impact on lowering systolic BP compared with physical activity, salt restriction, and weight loss. The DASH diet reduced systolic BP levels within 2 weeks of starting the plan. Not only was BP reduced, but total cholesterol and low-density lipoprotein were lower, too.


Clinical Presentation 3


Which of the following risk factors is not commonly associated with pheochromocytoma?




  • A.

    Neurofibromatosis-1 (NF1)


  • B.

    von Hippel-Lindau (VHL) syndrome


  • C.

    Multiple endocrine neoplasia (MEN) type 1


  • D.

    Elevated succinyl dehydrogenase levels


  • E.

    Elevated RET



The correct answer is D


Comment: VHL disease is an autosomal dominant disorder with variable penetrance. The VHL protein gene is on chromosome 3p25 and functions normally as a tumor suppressor by inhibiting transcription elongation. Missense mutations outside the elongation binding domain can cause the VHL disease. Affected persons can develop cerebellar and retinal hemangiomas, pheochromocytoma, renal cell carcinoma, pancreatic cysts, and endolymphatic inner ear tumors. Although some VHL families present with MEN-2, others may present only with pheochromocytoma. Thus, patients presenting with apparently isolated pheochromocytoma should be evaluated for VHL disease and MEN-2.


Clinical Presentation 4


In a 17-year-old woman with no known established cardiovascular disease, a mean BP is 142/78 mm Hg and a glomerular filtration rate (GFR) is 56 mL/min/1.73 m 2 despite the use of enalapril 10 mg twice daily, amlodipine 5 mg twice daily, and atenolol 25 mg daily.


Which of the following would be the best first step in terms of pharmacological therapy?




  • A.

    Add spironolactone, 25 mg daily


  • B.

    Add terazosin, 1 mg twice daily


  • C.

    Increase atenolol to 50 mg daily.


  • D.

    Change enalapril to losartan HCT, 100/12.5 mg daily, and stop atenolol.



Correct answer is A


Comment: Spironolactone is the most effective fourth medication for treating HTN in patients already on treatment with triple regimens that include an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB), amlodipine, and a thiazide-like diuretic.


Clinical Presentation 5


An 18-year-old female who is a devoted singer has hypertension, which has been well controlled with enalapril for the past month. She calls to report a new, intolerable side effect, and she requests to be switched to a different drug.


Which of the following adverse effects is most likely to be intolerable to this patient?




  • A.

    Frequent urination


  • B.

    Dysgeusia


  • C.

    Dry cough


  • D.

    Headache



The correct answer is C


Comment: Dry cough, which is the most common side effect reported with ACE inhibitors, would be intolerable to a singer, and develops in approximately 10% of patients treated with ACE inhibitors. In half of these patients, the ACE inhibitor has to be discontinued.


Clinical Presentation 6


A 16-year-old male presented for evaluation of treatment-resistant HTN. He recalled being told that his systolic BP was high when he was in elementary school; however, he did not begin taking antihypertensive medications until age 10 years. Despite multiple antihypertensive regimens, his HTN has been difficult to control and is consistently above his BP target (<140/90 mm Hg) in multiple settings, including the physician’s office and at home. His current regimen consists of 320 mg of valsartan, 200 mg/d of extended-release metoprolol, and 10 mg/d of amlodipine, which were his only medications. He had previously taken 25 mg/d of hydrochlorothiazide (in combination with valsartan and metoprolol); however, this was discontinued because of the inability to reach his BP target and the development of hypokalemia (potassium level, 2.8 mmol/L). The patient reported that he adhered strictly to a low-sodium diet, rarely drank alcohol, never smoked, and rode a stationary bicycle for 60 minutes every day. He had intentionally lost about 11.4 kg in the past 4 years. His medical history included obesity, hyperlipidemia, impaired fasting glucose levels, hypothyroidism treated with thyroid hormone replacement therapy, gout, and obstructive sleep apnea treated with continuous positive airway pressure (CPAP). He was recently evaluated in the sleep clinic, and his obstructive sleep apnea was being adequately treated with his current CPAP settings. The patient reported adherence to his antihypertensive medication regimen and CPAP use. He denied using nonsteroidal antiinflammatory drugs or stimulant medications. He also denied headaches, palpitations, and diaphoresis.


Findings on physical examination were as follows: BP, 158/88 mm Hg (average of six readings in the left arm sitting); pulse, 51 beats/min and regular; and body mass index (BMI) 47 (weight in kg/kg/height in m 2 ).


Other than an obese appearance, his physical examination was unremarkable.


Laboratory testing yielded the following results (reference ranges provided parenthetically): sodium level, 140 mEq/L (135–145 mEq/L); potassium level, 3.3 mmol/L (3.6–5.2 mmol/L); and creatinine level, 0.8 mg/dL (0.8–1.3 mg/dL). Electrocardiography revealed sinus bradycardia with borderline left ventricular hypertrophy. Renal ultrasonography revealed normal kidney size with no evidence of renal artery stenosis. Echocardiography revealed a mild increase in left ventricular thickness, normal function, and no valvular abnormalities.


In addition to advising continued efforts toward weight loss, which one of the following is the most appropriate next step in the management of this patient’s HTN?




  • A.

    Advise follow-up blood pressure check in 3 months.


  • B.

    Increase extended-release metoprolol to 300 mg/day.


  • C.

    Evaluate for identifiable (secondary) causes of hypertension.


  • D.

    Refer the patient to a cardiologist.


  • E.

    Add clonidine.



Correct answer is C


Comment: This patient has medically complicated obesity, as evidenced by his body weight and multiple weight-related comorbid conditions (HTN, hyperlipidemia, impaired fasting glucose level, and obstructive sleep apnea). Additional weight loss, including consideration of bariatric surgery, will be paramount to improving BP control and lowering his overall cardiovascular risk. However, in the meantime, maintaining his current drug regimen is not appropriate. Further titration of his beta-blocker dose is unlikely to provide additional BP lowering and would likely induce symptomatic bradycardia given his current resting heart rate. His HTN was considered to be resistant because he had been unable to reach his BP goal despite taking three appropriate medications.


After completing a thorough review of adherence to lifestyle decisions and medications, the most appropriate next step in management would be to evaluate for identifiable secondary causes of HTN such as sleep apnea, renovascular disease, primary aldosteronism, Cushing syndrome, pheochromocytoma, and thyroid disease. This patient’s history of developing HTN at a young age (<10 years) and hypokalemia with diuretic use are additional factors that suggest the need to evaluate for other contributors to his HTN.


Clonidine can be used as therapy for essential HTN and would be a reasonable agent to add; however, at this point, it is important to pursue other etiologies.


Further laboratory tests revealed: a thyroid-stimulating hormone level of 3.14 mIU/mL (0.30–5.0 mIU/mL); 24-hour urinary free cortisol level, 17 µg (3.5–45 µg/24 h); plasma free metanephrine level, <0.20 nmol/L (<0.50 nmol/L); plasma free normetanephrine level, 0.24 nmol/L (<0.90 nmol/L); plasma aldosterone concentration (PAC), 16 ng/dL (1–21 ng/dL); plasma renin activity (PRA) level, <0.6 ng/mL/h (0.6–3.0 ng/mL/h); and PAC:PRA ratio, 27 (<20).


Clinical Presentation 7


Which one of the following best explains this patient’s very low plasma renin level?




  • A.

    Hypoaldosteronism


  • B.

    Primary hyperaldosteronism


  • C.

    Restriction of dietary sodium


  • D.

    Pheochromocytoma



The correct answer is B


Comment: In the setting of a normally responsive renin-angiotensin-aldosterone (RAA) axis, hypoaldosteronism (e.g., primary adrenal insufficiency) would cause an elevated PRA, not a suppressed one as in this patient. In contrast, primary aldosteronism promotes negative feedback on the RAA axis, resulting in a low PRA level, making this the correct answer. Concomitant antihypertensive drug therapy is important to consider when interpreting the results of renin and aldosterone levels. ACE inhibitors (ACEIs) block conversion of angiotensin I to angiotensin II, which in turn decreases aldosterone levels. This inhibition actually causes elevated renin secretion through the RAA axis feedback. As a result, a low PRA level in a patient taking an ACEI or ARB should increase clinical suspicion for primary aldosteronism, as in this case. Restriction of dietary sodium results in increased aldosterone production via increased renin secretion. In pheochromocytoma, catecholamines are released that increase sympathetic neural tone and increase renin levels.


Clinical Presentation 8


Which one of the following is the most appropriate next test to confirm the diagnosis?




  • A.

    Sodium-loading test with measurement of 24-hour urine aldosterone excretion


  • B.

    Computed tomography (CT) of the adrenal glands


  • C.

    Adrenal venous sampling (AVS)


  • D.

    BP response to a trial of a mineralocorticoid antagonist


  • E.

    Fine-needle aspiration biopsy of the adrenal glands



The correct answer is A


Comment: An increased PAC/PRA ratio alone is not diagnostic for primary aldosteronism. Primary aldosteronism must be confirmed by demonstrating inappropriate aldosterone secretion. Confirmatory testing can be done by evaluating 24-hour urine aldosterone levels after a sodium load, making this the correct answer. This functions to maximally suppress intrinsic aldosterone secretion. CT of the adrenal glands is not a good confirmatory study because it does not provide information regarding the functional status of any potentially visualized abnormalities. Surgical removal of an adenoma, which has not been proven to be functional, would be premature, so this would not contribute to the patient’s current management. Adrenal venous sampling is useful to distinguish between subtypes of primary aldosteronism but is only indicated after confirmatory blood testing is complete. Empirical treatment with a mineralocorticoid antagonist would be premature because some patients may benefit from surgical intervention. Fine-needle aspiration biopsy of the adrenal glands has no role in the workup of primary aldosteronism. Occasionally, fine-needle aspiration biopsy is useful in the investigation of an adrenal mass suspected to be metastatic disease in the setting of a known malignancy.


However, it has no role in an isolated adrenal mass workup because cytology cannot distinguish a benign adrenal mass from adrenal carcinoma.


The patient was referred for a sodium-loading test with measurement of 24-hour urine aldosterone excretion. The patient consumed a 6000-mg sodium diet for 3 days. His 24-hour urine collection revealed the following results: urine volume, 3008 mL; creatinine concentration, 0.8 mg/dL (0.8–1.3 mg/dL); 24-hour urine sodium level, 343 mmol/24 h (40–217 mmol/24 h); sodium concentration, 114 mmol/L (135–145 mmol/L); and aldosterone, 17 µg/24 h (<12 µg/24 h if 24-hour urine sodium level is >200 mmol).


Because the urine aldosterone level was well above the 12 µg/24 h cutoff, the diagnosis of primary aldosteronism, resulting from either adrenal adenoma or idiopathic adrenal hyperplasia, was entertained. CT of the abdomen with 3-mm cuts through the adrenal glands did not demonstrate adrenal masses.


Clinical Presentation 9


Which one of the following is the most appropriate next step in management?




  • A.

    Radionuclide scintigraphy of the adrenal glands


  • B.

    Magnetic resonance imaging (MRI) of the adrenal glands


  • C.

    Follow-up CT of the adrenal glands in 6 months


  • D.

    Proceed directly to surgery


  • E.

    Adrenal venous sampling



The correct answer is E


Comment: Radionuclide scintigraphy with iodocholesterol was formerly used to correlate adrenal function with visualized anatomic lesions to help clarify a target for possible surgical resection. However, this patient has no clear radiographic evidence of an adrenal adenoma. An MRI of the adrenal glands cannot rule out unilateral aldosterone-producing disease and would not contribute any additional information for this patient. Although serial CT imaging, like MRI, may reveal a new adrenal lesion, nonfunctioning adrenal incidentalomas are relatively common in patients older than age 40 years, and this would not provide any information regarding whether the lesion was hormonally functional. Moreover, aldosterone-producing adenomas can be very small, so CT imaging may not universally exclude this disorder. Adrenal venous sampling performed by an experienced interventional radiologist is the only means of detecting laterality of disease. Even though AVS is not available at all medical centers, it should be considered in all patients willing to pursue surgical management. If not initially pursued, it should be reconsidered in patients who either do not tolerate or do not benefit from medical management. Proceeding directly to adrenalectomy without prior AVS in this case would not be indicated because the disease could be bilateral. AVS was offered, but the patient did not wish to pursue surgical treatment. In the absence of an obvious adrenal carcinoma or adrenal adenoma, he was thought most likely to have the idiopathic bilateral hyperplasia subtype of primary aldosteronism.


Clinical Presentation 10


Which one of the following is the most appropriate empirical treatment option for this patient?




  • A.

    Low-dose glucocorticoid


  • B.

    Mineralocorticoid antagonist


  • C.

    Triamterene


  • D.

    More aggressive salt restriction


  • E.

    Percutaneous radiofrequency ablation



The correct answer is B


Comment: Low-dose glucocorticoid is only used as first-line therapy in the subtype of primary aldosteronism known as glucocorticoid-remediable aldosteronism, which is a very rare genetic condition that needs to be confirmed with specific genetic testing before initiating treatment. The best treatment option for this patient with bilateral disease is medical treatment with a mineralocorticoid receptor antagonist such as spironolactone or eplerenone. Triamterene is a potassium-sparing diuretic agent that also targets the distal renal tubule; however, unlike spironolactone and eplerenone, it is not an aldosterone antagonist and is therefore not the preferred agent. A low-salt diet is a reasonable recommendation for all patients with HTN but would not be sufficient for this patient. Percutaneous radiofrequency ablation is occasionally used to treat unilateral adrenal lesions but would clearly not be useful in this scenario.


The patient began a therapeutic trial of an aldosterone antagonist, eplerenone, at a dose of 50 mg by mouth twice daily. After 2 months of therapy, his valsartan and metoprolol doses were decreased by 50%, with systolic BP maintained in the range of 135 to 145 mm Hg.


Clinical Presentation 11


Which of the following patient vignettes is most consistent with true resistant HTN in a 19-year-old patient without established cardiovascular or chronic kidney disease?




  • A.

    Office BP (mean of repeated measurements) 146/96 mm Hg on losartan 100 mg daily, and amlodipine 5 mg daily


  • B.

    Office BP (mean of repeated measurements) 136/86 mm Hg on losartan 100 mg daily, amlodipine 5 mg daily, and hydrochlorothiazide 25 mg daily, with a mean home BP readings of 132/82 mm Hg


  • C.

    Office BP (mean of repeated measurements) 146/90 mm Hg on losartan 100 mg daily, amlodipine 5 mg daily, and hydrochlorothiazide 25 mg daily, with a mean home BP readings of 126/76 mm Hg



The correct answer is C


Comment: Resistant HTN is defined as HTN that is poorly responsive to treatment and requires the use of multiple medications to achieve acceptable BP ranges.


Clinical Presentation 12


A 19-year-old male reports to the emergency room after being seen at his primary care physician’s clinic. His BP on entering the emergency room is 171/100 mm Hg and he has shortness of breath with a headache. He has a past medical history of hypertension for 3 years. He denies smoking and illicit drug use. He rarely drinks alcohol. His medications are the following: lisinopril 20 mg once per day and hydrochlorothiazide 25 mg once per day. His laboratory tests are all within normal limits.


Which of the following is appropriate for this patient?




  • A.

    Check medication adherence.


  • B.

    Emphasize restriction of sodium in diet.


  • C.

    Potentially increase the current dose of hydrochlorothiazide to 50 mg daily.


  • D.

    Reevaluate in a week.


  • E.

    All of the above.



The correct answer is E


Comment: The following can all contribute to the development of both hypertension and resistant hypertension: obesity, physical inactivity, a diet high in salt, heavy alcohol drinking, and poor adherence to medication.


Clinical Presentation 13


Which of the following hypertensive scenarios requires immediate treatment?




  • A.

    A 3-year-old boy with a history of renal disease and stage I HTN, now with systolic BP (SBP) >the 99th percentile


  • B.

    A 2-month-old girl admitted for labial abscess with SBP >the 99th percentile and tachycardia


  • C.

    A 10-year-old girl admitted for asthma with SBP at the 98th percentile with tachypnea


  • D.

    A 4-year-old boy admitted for bronchiolitis with SBP >the 99th percentile with lethargy



The correct answer is D


Comment: The most likely of these to need immediate treatment is the child with bronchiolitis who has a hypertensive emergency; the elevation of the BP combined with the end-organ symptom of lethargy is highly concerning, especially in a setting of few other causes. Though option B could be considered hypertensive urgency, the BP is likely increased by the pain associated with the abscess, and therefore pain medications could be tried first. The asthmatic only has stage I HTN, which is most likely influenced by the steroid treatment of asthma, and his tachypnea is likely from the asthma. Finally, the patient with a history of HTN and renal failure would be considered a chronic patient, and though oral medications could be used, a conversation with the nephrologist should occur.


Clinical Presentation 14


A 17-year-old woman with long-standing lupus nephritis presents to her physician for her biannual checkup. She is currently taking no medication and she feels generally well.


On physical examination, her BP is 160/98 mm Hg. Pressures were equal in both arms. Previous BP readings have been in the range of 130/70 mm Hg.


Her physician asks her to return a week later for a recheck of the pressure. At that time, repeat blood pressure was 158/100 mm Hg. The remainder of the physical examination was normal.


Laboratory studies were serum creatinine 4.3 mg/dL, urea nitrogen 38 mg/dL, and potassium 5.1 mEq/L. A 24-hour urine protein was 1.2 g. These laboratory results were only slightly higher than those taken 6 months earlier. This patient is presumed to have HTN as the result of her lupus nephritis.


What is the first-line antihypertensive agent for this patient?




  • A.

    Thiazide diuretic


  • B.

    ACEI


  • C.

    Sympathetic blocker such as Aldomet


  • D.

    Beta-blocker



The correct answer is B


Comment: In chronic kidney disease (CKD) with proteinuria, either ACEIs or ARBs reduce urinary protein and slow the progression of renal failure.


Hypertension is present in approximately 80% to 85% of patients with CKD and is thought to be multifactorial (sodium retention, increased activity of the renin-angiotensin system, and enhanced activity of the sympathetic nervous system).


In patients with proteinuria (defined as protein excretion above 500–1000 mg/day) CKD, first-line therapy consists of an ACEI or ARB as first-line therapy for the treatment of HTN. , ACEIs, in addition to reducing intraglomerular pressure, reduce the excretion of urinary protein (both of which delay the progression of renal failure). ARBs have a similar effect. , Aside from BP control, the aim is to reach less than 1000 mg/day of protein spilling into the urine.


In patients with edema, a thiazide diuretic can be added as a second-line drug; chlorthalidone is preferred over hydrochlorothiazide because of its longer duration of action. A dihydropyridine calcium channel blocker (CCB) is appropriate as a second-line drug for patients without fluid retention. Neither a beta-blocker nor a sympathetic, such as Aldactone, demonstrate the protective effect of ACEIs or ARBs.


Clinical Presentation 15


A 12-year-old girl with CKD stage III (GFR 34 mL/min/2.73 m 2 ) is hypertensive and her BP is not controlled on a regimen of hydralazine 20 mg three times a day, atenolol 50 mg daily, and 12.5 mg of hydrochlorothiazide daily.


Which of the following is (are) most appropriate to choose (select all that apply)?




  • A.

    Switch diuretic to chlorthalidone.


  • B.

    Consider other medications in lieu of hydralazine and atenolol.


  • C.

    Add clonidine.


  • D.

    Increase hydrochlorothiazide to 25 mg.



The correct answers are A and B


Comment: Evidence suggests greater cardiovascular protection with other classes of antihypertensive agents (ACEIs/CCBs) versus beta-blockers (atenolol). Hydrochlorothiazide is not as effective a diuretic agent as chlorthalidone.


To initiate therapy to lower this patient’s BP, hydrochlorothiazide should be changed to chlorthalidone, and next, a substitute should be found for hydralazine (either amlodipine or combination ACEI/ARB, preferably in a combination tablet).


Three maneuvers can lead to better BP control over shorter periods. First, use combination antihypertensive agents earlier and more often, especially in HTN stage II or higher; second, identify resistant HTN earlier and use spironolactone when possible. Third, avoid less efficacious medications (hydralazine and clonidine) from days gone by.


Clinical Presentation 16


You evaluate a 15-year-old girl with chronic HTN whose BP remains above target despite a daily regimen of benazepril 20 mg, chlorthalidone 25 mg, and amlodipine 10 mg.


What is next on your therapeutic plan?




  • A.

    Add an agent from another class, such as hydralazine or clonidine.


  • B.

    Characterize the patient as having resistant HTN and initiate therapy with 25 mg of spironolactone (potassium levels permitting).


  • C.

    Add an ARB.


  • D.

    Switch from amlodipine to verapamil.



Correct answer is B


Comment: Resistant HTN is defined as BP not controlled on a complementary three-drug regimen with a diuretic as one of the agents. Spironolactone has become a “go-to” agent for treating resistant HTN. , If it works, it may allow the patient to discontinue other antihypertensive agents. It is a pharmaceutical backbone for resistant HTN treatment.


Clinical Presentation 17


You are seeing a 15-year-old male for the first time. He has untreated HTN (168/106 mm Hg and BP has been elevated on at least three occasions). There is currently no evidence of target organ dysfunction (heart, neurological, or eyegrounds).


From a therapeutic perspective, what is the best initial approach?




  • A.

    Initiate treatment with 25 mg of hydrochlorothiazide.


  • B.

    Consider initiating treatment with a two-agent combination pill.


  • C.

    Delay pharmacologic intervention and treat with salt restriction.


  • D.

    Consider initiating treatment with triple drugs including an ACEI, a CCB, and a thiazide diuretic.



The correct answer is B


Comment: The patient qualifies for a diagnosis of stage II HTN (BP >160/>100 mm Hg). A single agent will not suffice to lower the patient’s BP to target level. Many studies have also demonstrated that combination therapy reduces the risk of cardiac events, is more efficacious, and improves adherence, BP control, and time-to-target BP. Combination therapy with appropriately chosen agents (such as amlodipine and an ARB) augments effects of either agent taken alone. The days of “maxing out” monotherapy before initiating combinations are over.


Clinical Presentation 18


A 15-year-old male presents to your office for a follow-up of his BP medication. He is currently taking amlodipine 10 mg/d along with lisinopril 20 mg/day. He has been doing well and has had no adverse effects from this regimen. His BP readings at home and in the office average about 130/80 mm Hg. He has no history of cardiovascular disease. Nevertheless, he asks you if any simple changes can be made to decrease his cardiovascular risks.


Based on current literature, what intervention may decrease his cardiovascular-related morbidity and mortality?




  • A.

    Adding hydrochlorothiazide to the regimen


  • B.

    Taking his BP medication at bedtime


  • C.

    Adding a beta-blocker to the regimen


  • D.

    No change is needed; his BP is well controlled.



The correct answer is A


Comment: When two or more drugs are used, they should be from different antihypertensive drug classes. In most patients, the drugs should be selected from among the three preferred classes (i.e., ACEIs [or ARBs], CCBs, and thiazide diuretics).


Evidence suggests treating with the combination of an ACEI (or ARB) and a CCB, preferably a dihydropyridine calcium blocker. In addition, it is also recommended to prescribe these two agents as a single-pill combination, if feasible. Single-pill combinations lead to greater BP reduction, increased attainment of BP goals, and better medication adherence as compared with free equivalents, in which the two drugs are prescribed separately.


The combination of an ACEI (or ARB), a CCB with a thiazide diuretic is a reasonable alternative, particularly in patients who have conditions that can benefit from a thiazide diuretic (e.g., edema, osteoporosis, calcium nephrolithiasis with hypercalciuria).


Initially, serum electrolytes and serum creatinine should be monitored 1 to 3 weeks after initiation or titration of ACEIs, ARBs, mineralocorticoid receptor antagonists, and diuretics. In patients on stable doses of medications, electrolytes and creatinine are typically monitored annually.


If BP is uncontrolled, it is typically recommended to escalate doses of individual antihypertensive drugs to at least half the maximum recommended dose (i.e., to a moderate or high dose) before adding additional therapy. After goal BP is attained, patients should be followed every 3 to 6 months.


Clinical Presentation 19


A 17-year-old woman has been on antihypertensive drug therapy for the past 3 months. During her most recent visit, her fasting blood glucose level was found to be 243 mg/dL.


Which agent in an antihypertensive drug regimen would be most likely to have caused her glucose intolerance?




  • A.

    Diltiazem


  • B.

    Lisinopril


  • C.

    Amlodipine


  • D.

    Hydrochlorothiazide


  • E.

    Minoxidil



The correct answer is D


Comment: Thiazides are known to produce mild hyperglycemia. It is typically not of clinical consequence in nondiabetics and can be minimized by correcting any associated hypokalemia (the two side effects appear to be linked). The effect on plasma glucose is typically very small, with the low doses of thiazides typically prescribed for treating hypertension because low doses have minimal natriuretic effects.


Clinical Presentation 20


A definite contraindication for the use of ACEIs and ARBs includes which one of the following?




  • A.

    Asthma


  • B.

    Bilateral renal artery stenoses


  • C.

    Diabetes


  • D.

    Tachycardia


  • E.

    Hypokalemia



The correct answer is B


Comment: Angiotensin II (Ang II) is necessary for maintaining efferent arteriole resistance in this setting. Reducing Ang II levels, or Ang II effects, can reduce GFR and cause kidney failure in this setting. In general, contraindications to ACEI use include hyperkalemia (>5.5 mmol/L), renal artery stenosis, pregnancy, or prior adverse reaction to ACEIs including angioedema.


Clinical Presentation 21


A 4-year-old boy was admitted to our hospital because of hyperpigmented macules in 2008. The pigmentations were present when he was born, but this was his first hospital admission. On physical examination, axillary freckling and multiple café-au-lait spots ≥5 mm in size were revealed, spread over the skin of the trunk. His height was 100 cm (10–50th percentile), and weight was 15 kg (10–25th percentile). He was normotensive. Slit-lamp examination showed the presence of more than 10 Lisch nodules for each eye. Patient was diagnosed as having NF1. The p.R304 pathogenic mutation (also known as c.910C > T), located in coding exon 9 of the NF1 gene, was detected in the genetic examination of NF1.


When the patient was 5 years old, he was admitted to the hospital because of epistaxis in 2009. His blood pressure was 170/100 mm Hg and heart rate was 108/min. Bilateral radial/femoral pulses were bounding. There were no abdominal and carotid bruits. Electrocardiogram was normal. Clinical laboratory investigations revealed that kidney and liver function tests, blood cell counts, urinalysis, serum electrolytes, and 24-hour urine levels of catecholamines were all within normal ranges, but plasma renin activity was elevated, >500 (1–6.5 ng/mL/h). Kidney Doppler ultrasound showed bilateral renal arterial stenosis. Abdominal computed tomography (CT) angiography revealed a severe right ostial renal artery stenosis, total occlusion of the left renal artery and the celiac trunk, and moderate stenosis of the superior mesenteric artery and collateral circulation for these arteries. Amlodipine and propranolol were initiated. Percutaneous transluminal renal angioplasty (PTRA) was performed. During PTRA, contour irregularity and minimal stenosis in the ostium of the right renal artery and perivascular diaphragmatic collateral arteries at the level of the left renal artery orifice were observed. A coronary balloon catheter was used for the right renal artery. For the left renal artery, surgery was performed, and the occluded segment was removed and anastomosis was made. After these procedures, BP returned to normal levels. Previously initiated amlodipine and propranolol were discontinued.


After a few years, his BP became moderately high. An echocardiographic examination revealed hypertrophy of the interventricular septum, and an ophthalmological examination revealed grade 1 to 2 hypertensive retinopathy. Ophthalmic fundus examination showed tiny veins twisted into a spiral shape and corkscrew retinal vessels. Antihypertensive treatment was initiated again (amlodipine and metoprolol). When he was 17 years old, he was admitted to the hospital because of 150/100 mm Hg BP. Conventional angiography was performed. Abdominal aorta was low in caliber. The celiac truncus was markedly dilated and its branches were patent. It was occluded at the ostium of the superior mesenteric artery and was filled from celiac truncus via the dilated pancreaticoduodenal arch, and its branches were patent. The segment containing the previously placed intravascular stent at the level of the right renal artery ostium was patent. Aorto-left renal artery neoanastomosis was patent and showed smooth wall features. In the nephrogram phase, both kidneys showed smooth contours and homogeneous opacifications. In the right carotid system, the communicating segment of the internal carotid artery was obstructed/severely stenotic, and collateral flow was monitored. The posterior cerebral artery was also patent. The anterior cerebral artery segment was hypoplastic. In the left carotid system, there was an aneurysm 2 mm in size on the posterior wall of the ophthalmic segment of the left internal carotid artery.


What is the cause of hypertension in the patient?




  • A.

    Renal vascular disease


  • B.

    Mutation in the NF1 gene


  • C.

    Overactivity of the renin-angiotensin system (RAS)


  • D.

    Carotid artery stenosis



The correct answer is B


Comment: HTN is a frequent finding in patients with NF1 and may develop during childhood. If the vascular stenosis resulting from loss of neurofibromin expression occurs in the renal arteries, the patient develops renovascular HTN. The RAS plays an important role in the development of HTN. In unilateral RAS, decreased kidney blood flow stimulates the production of renin, angiotensin II, and aldosterone. Aldosterone production causes sodium and water retention, but these excesses of sodium and water are rapidly excreted by the contralateral kidney by pressure natriuresis. But in bilateral RAS, as in our patient, although there is water and salt retention with a similar mechanism, natriuresis cannot be achieved because of decreased blood flow in both kidneys. The increased plasma volume suppresses plasma renin activity, and it causes volume-mediated HTN not renin-mediated. HTN in NF1 is a complicated problem. Approximately 15% of NF1 patients have HTN, either primary HTN or secondary HTN because of RAS. Because of stenosis, kidney blood flow decreases and plasma renin level is measured as high. ,


In our patient, because the plasma renin level was high and bilateral RAS was detected, treatment was started with antihypertensive medications, then PTRA was performed and a stent was placed in a renal artery. The patient was normotensive in the follow-up period, and antihypertensive drugs were discontinued. However, over the years, our patient developed mild HTN, and RAS overactivity developed again in follow-up. In our patient, the renin level was normal, and it was seen that renal artery blood flow was patent after PTRA. HTN was seen to regress.


Clinical Presentation 22


A 16-year-old female (162 cm tall, weight 77 kg, and 160 cm tall) is diagnosed with stage I hypertension. Her BP averages 135/85 mm Hg. She has no other comorbid conditions and is otherwise in excellent health.


What initial therapy would be most appropriate for her?




  • A.

    Clonidine


  • B.

    Diltiazem


  • C.

    Hydrochlorothiazide


  • D.

    Prazosin


  • E.

    Lifestyle modification



The correct answer is E


Comment: Patients with stage I hypotension (BP 130–139/80–89 mm Hg) who are at low risk for cardiovascular (CV) disease should be initially treated with nonpharmacologic, lifestyle improvements, with reassessment after 3 to 6 months to determine if they have met their BP goal of <130/<80 mm Hg.


Clinical Presentation 23


A 14-year-old male was recently diagnosed with stage I hypertension. His history is unremarkable except that both parents and a grandparent died from systolic heart failure at a relatively early age.


Which antihypertensive drug would be best at preventing heart failure if prescribed to this patient?




  • A.

    An ACEI


  • B.

    A beta-blocker


  • C.

    An alpha-blocker


  • D.

    A CCB


  • E.

    A thiazide diuretic



The correct answer is E


Comment: The correct answer is a thiazide diuretic. Studies have shown that alpha-blockers actually double the risk of heart failure compared with a diuretic, and both CCBs and ACEIs are also inferior to a diuretic for preventing congestive heart failure (CHF).


Among patients selected for antihypertensive drug treatment, therapy should be initiated with either one drug (i.e., monotherapy) or two drugs (i.e., combination therapy, preferably in a single pill to improve adherence). ,


In general, patients with a SBP 10 to 20 mm Hg above goal and/or a diastolic BP 10 mm Hg above goal should have antihypertensive drug therapy initiated with low to moderate doses of two agents with complementary mechanisms of action. Some experts begin with two agents in patients with stage II hypertension (i.e., SBP ≥140 mm Hg and/or diastolic BP ≥90 mm Hg), whereas other experts would initiate therapy with two drugs in patients whose SBP is ≥150 mm Hg and/or diastolic BP is ≥90 mm Hg.


Clinical Presentation 24


A 16-year-old female has recently been diagnosed with HTN by her primary care physician. Her BP during the past two visits has averaged 145/95 mm Hg. She is 85 kg, 162 cm tall, and exercises regularly. Her electrocardiogram indicates mild left ventricular hypertrophy. Her plasma lipids and fasting glucose are normal. She is a smoker (one pack per day). She is advised to enter a smoking cessation program to reduce cardiovascular risk, adopt a DASH diet, and maintain her daily routine of 30 minutes per day of aerobic exercise, with the target of losing at least 5 kg over the next 6 months. Her physician then discusses the options for drug therapy.


Which of the following is the most appropriate drug selection for this patient?




  • A.

    Furosemide plus losartan


  • B.

    Hydralazine


  • C.

    Hydrochlorothiazide plus ramipril


  • D.

    Hydrochlorothiazide


  • E.

    Amlodipine plus metoprolol



The correct answer is C


Comment: This patient will need at least two drugs to reduce her SBP from 145 to <130 mm Hg. If she is successful in losing weight, with concomitant reduction of BP, one of the two drugs can be reduced in dosage or discontinued. The 2017 American College of Cardiology/American Heart Association recommends therapy with two drugs consisting of either a thiazide, an ACEI (or ARB), and a CCB. Note that the side effects of the thiazide (mild hypokalemia) can be countered by either an ACEI or an ARB (which can produce mild hyperkalemia).


Combination therapy lowers BP more than monotherapy and increases the likelihood that target BP will be achieved in a reasonable time. In addition, using two drugs may lead to attainment of goal BP with lower doses of each medication, and this reduces the risk of dose-related side effects.


Regardless of whether treatment is begun with one or two drugs, the initial drug dose should generally be low. However, by far the most important strategy for ultimately achieving BP control is to avoid therapeutic inertia. Therapeutic inertia is defined as failing to initiate or adjust/intensify prescribed drug therapy despite the recognition of uncontrolled HTN.


When two drugs are used, they should be from different antihypertensive drug classes. In most patients, the drugs should be selected from among the three preferred classes (i.e., ACEIs [or ARBs], CCBs, and thiazide diuretics).


Clinical Presentation 25


An 18-year-old overweight adolescent male was recently diagnosed with hypertension (143/92 mm Hg) and type 2 diabetes.


Which of the following would be the best drug of first choice to manage his hypertension?




  • A.

    Atenolol


  • B.

    Hydrochlorothiazide


  • C.

    Lisinopril


  • D.

    Nifedipine


  • E.

    Metoprolol



The correct answer is C


Comment: Patients with a history of either diabetes or kidney disease should be given an ACEI or an ARB to prevent the development, or further progression, of kidney disease.


Patients treated with antihypertensive drug therapy should be evaluated (either in person or by telehealth) every 2 to 4 weeks until their BP is at goal. Waiting 4 weeks to reevaluate after starting or intensifying therapy is typically appropriate to permit long-acting antihypertensive drugs enough time to manifest their full BP-lowering effect. If BP is uncontrolled, we typically escalate doses of individual antihypertensive drugs to at least half the maximum recommended dose (i.e., to a moderate or high dose) before adding additional therapy. After goal BP is attained, we usually follow patients every 3 to 6 months.


Clinical Presentation 26


A 17-year-old man presents with HTN, asthma, and atrial fibrillation. He is able to walk six blocks before stopping to rest, and his echocardiogram shows an ejection fraction of 57%. His rhythm is irregularly irregular, with a ventricular response between 110 and 160/min.


Which of the following agents would be the safest in treating his HTN and controlling his ventricular response?




  • A.

    Atenolol


  • B.

    Benazepril


  • C.

    Hydrochlorothiazide


  • D.

    Losartan


  • E.

    Verapamil



The correct answer is E


Comment: This is the best choice. It would increase the atrioventricular node’s effective refractory period and slow his ventricular rate, while also reducing arterial BP. This is an example of treating a patient with a comorbid condition atrial fibrillation (AF).


AF is an increasingly prevalent condition and the most common sustained arrhythmia encountered in ambulatory and hospital practice. Several clinical risk factors for AF include age, sex, valvular heart disease, obesity, sleep apnea, heart failure, and HTN.


Of all the risk factors, hypotension is the most commonly encountered condition in patients with incident AF.


The RAA system has been demonstrated to be a common mechanistic link in the pathogenesis of hypertension and AF.


Clinical Presentation 27


An 18-year-old woman with a history of mild HTN is planning to begin a family with her husband in the immediate future. She is currently being treated with a combination of hydrochlorothiazide and losartan.


Which agent could she be switched to that has a well-established track record for safety in the treatment of essential hypertension during pregnancy?




  • A.

    Aliskiren


  • B.

    Captopril


  • C.

    Candesartan


  • D.

    Methyldopa


  • E.

    Propranolol



The correct answer is D


Comment: Methyldopa has the best, most well-established track record for safety as an antihypertensive drug in pregnancy.


ARBs are contraindicated in pregnancy. Women contemplating pregnancy should be counseled to discontinue these medications before conception. Exposure to such drugs may result in a decrease in placental blood flow, which can result in oligohydramnios, renal failure, low birth weight, cardiovascular anomalies, spontaneous abortions, and other abnormalities.


Clinical Presentation 28


A 16-year-old patient was admitted to the emergency department for severe chest pain and was found to have severe hypertension (197/119 mm Hg).


What intravenous medication would you choose to manage his condition?




  • A.

    Atenolol


  • B.

    Furosemide


  • C.

    Phenylephrine


  • D.

    Sodium nitroprusside



The correct answer is D


Comment: Intravenous sodium nitroprusside is one of the drugs of choice for rapid lowering of SBP to <120 mm Hg (within 20 minutes) in the setting of a dissecting aorta. Most other hypertensive emergencies do not call for such rapid changes in BP because of the overriding concern about reductions in cerebral blood flow associated with rapid drops in BP.


The traditional drug of choice for therapy of hypertensive emergencies is sodium nitroprusside.


Intravenous labetalol produces a prompt, controlled reduction in BP and is a promising alternative.


Other agents used are diazoxide, trimethaphan camsylate, hydralazine, nitroglycerin, and phentolamine. However, all these agents have disadvantages, including unpredictable antihypertensive effects, difficult BP titration, and serious potential adverse effects such as profound hypotension, reduced renal blood flow, and increased myocardial workload. Most patients with hypertensive urgencies can be effectively treated with orally or sublingually administered agents. Older regimens of reserpine, methyldopa, or guanethidine, with their slow onsets and long durations of action, have been largely replaced by clonidine and nifedipine. Captopril and minoxidil have also been used with some success. Despite the lack of comparative trials with traditional agents, demonstrated efficacy and desirable pharmacologic characteristics have made several new agents acceptable for therapy of hypertensive crises.


Clinical Presentation 29


Smoking increases arterial BP and accelerates vascular injury by which one of the following mechanisms?




  • A.

    Promoting endothelial dysfunction


  • B.

    Retention of sodium


  • C.

    Increased aldosterone protein


  • D.

    Activation of adducing gene


  • E.

    increases the production of catecholamines



The correct answer is A


Comment: Tobacco smoking is a potent promoter of endothelial dysfunction and activates vasoconstriction by inhibition of endothelium-dependent vasodilatation.


Clinical Presentation 30


A 15-year-old male indicates that his BP during the past year routinely stayed above 150/90 mm Hg despite limitation of sodium intake and regular exercise.


Antihypertensive therapy for the past 4 years consisted of thiazide diuretics with BP readings that averaged approximately 134/82 mm Hg. Current medications include amiloride/hydrochlorothiazide (5/50 mg daily); ramipril (10 mg daily), and diltiazem (240 mg daily).


On examination, the pertinent findings were BP 35 156/98 mm Hg, pulse 72 beats/min, weight 81 kg, and BMI 28 kg/m 2 . No ankle edema noted. Serum creatinine was 1.4 mg/dL; Na 146 mEq/L, K 3.4 mEq/L, Cl 95 mA/L, and CO 2 28 mEq/L. An electrocardiogram showed left ventricular hypertrophy and urinalysis trace protein.


Which one of the following studies is most likely to clarify the reason for his resistance to therapy?




  • A.

    GFR


  • B.

    Plasma aldosterone to renin ratio


  • C.

    Plasma catecholamines


  • D.

    Urinary microalbumin



The correct answer is B


Comment: The elevated serum sodium, high serum bicarbonate, and low serum potassium levels reflect a high probability of mineralocorticoid effect, which would explain the recent development of resistant hypertension. Therefore, measurements of aldosterone and renin are most likely to reveal this disturbance. Measurement of GFR, catecholamines, and microalbuminuria would not explain the electrolyte changes and are far less likely to add useful information regarding identifying the cause of treatment resistance, making options A, C, and D incorrect.


Clinical Presentation 31


Which one of the following statements is true regarding BP reduction in a hypertensive patient with normal renal function who is consuming a high-potassium, low-sodium (60 mEq/day) diet?




  • A.

    They will decrease their SBP by 12 to 14 mm Hg within a few months.


  • B.

    They will decrease their SBP by 12 to 14 mm Hg within a few months.


  • C.

    The diet has little effect on SBP but decreases diastolic BP by >10 mm Hg within a few months.


  • D.

    The diet is well tolerated, and thus no significant BP response is noted.


  • E.

    This diet increases the need for diuretics because of the high potassium load.



The correct answer is B


Comment: A review of the DASH diet studies indicates that the greatest benefit was seen among African-American women who were hypertensive, and the least significant effect on BP reduction in normotensive women. The DASH diet lowers BP but not weight or glucose control.


Clinical Presentation 32


A 16-year-old female with a BMI of 35 kg/m 2 and BP of 154/90 mm Hg is referred to you for albuminuria. Urine albumin/creatinine ratio is 370 mg/g creatinine (normal <30 mg/g). For the past 2 years, she has been receiving metoprolol 50 mg/day, and before that she had never been told she was hypertensive. On this visit, you note all laboratory tests are normal except for her fasting glucose of 124 mg/dL. Her current BP is 155/92 mm Hg and her pulse is 68 beats/min and regular.


Which one of the following choices provides for the patient’s best management?




  • A.

    Stay on a 1200 calorie/day (American Diabetic Association diet).


  • B.

    Stop the beta-blocker and begin an ACEI/diuretic combination and titrate to BP goal.


  • C.

    Increase metoprolol and titrate to BP goal.


  • D.

    Add an ACEI to her current regimen.


  • E.

    Recommend exercise for weight loss.



The correct answer is B


Comment: Clearly, this patient is obese and has impaired glucose tolerance. Moreover, she has HTN and is being treated with a drug at a very low dose, given her body size, that worsens glucose tolerance. Getting her to lose weight will take a long time, and even if successful, it will increase her total BP load over time. Increasing the dose of metoprolol will increase the likelihood of diabetes and worsen her morbidity. Adding an ACEI to an underdosed beta-blocker such as metoprolol does not alleviate the risk for diabetes development and, although it may improve HTN, will not have the same effect as a drug combination that is well documented in having additional BP-lowering effects in such patients.


Clinical Presentation 33


A 6-year-old girl has been hospitalized twice in the past 6 months with symptoms of CHF. A magnetic resonance angiogram showed complete occlusions of the right renal artery and high-grade stenosis (>90% narrowing of the left renal artery). Current medications include ramipril 5 mg daily and furosemide 40 mg daily. Physical examination shows BP 155/80 mm Hg, pulse 64 beats/min, lungs with occasional rhonchi, third heart sound appreciated, and a 2+ peripheral edema noted. Laboratory studies show hemoglobin 12 g/dL, serum creatinine 1.0 mg/dL, Na 139 mEq/L, K 3.9 mEq/L, and normal urinalysis.


Which one of the following recommendations would be most appropriate for this patient’s care?




  • A.

    Stenting of the left renal artery


  • B.

    Laparoscopic nephrectomy of right kidney


  • C.

    Withdrawal of ACEI


  • D.

    Improve BP to <129/80 mm Hg before any surgical intervention


  • E.

    Bilateral nephrectomy followed by renal replacement therapy



The correct answer is A


Comment: Stenting of the left renal artery reflects the benefit of renal revascularization when renal stenosis affects the entire functioning mass for patients with recurrent CHF. ACEIs have established survival benefits and should be continued, not stopped. Unilateral nephrectomy of the occluded kidney might lower BP levels, but low BPs are counterproductive and may worsen fluid retention when the remaining kidney has high-grade vascular disease.


Clinical Presentation 34


Which of the following choices most accurately describe(s) the role that ambulatory BP monitoring (ABPM) would play in a patient with white coat HTN (select all that apply)?




  • A.

    Average BP readings <140/90 mm Hg would confirm the presence of office or white coat hypertension.


  • B.

    Failure to lower nocturnal BP would signify higher risk of left ventricular hypertrophy.


  • C.

    The difference between day and night BP measurements would guide the choice of antihypertensive therapy.


  • D.

    Home BP reading can accurately predict white coat HTN.


  • E.

    Persistent elevations in nighttime readings of BP require the exclusion of sleep apnea as a cause for hypertension.



The correct answers are B and E


Comment: Sleep apnea interferes with the nocturnal fall in BP. Lack of nocturnal fall in BP predicts risk of left ventricular hypertrophy. ABPM BP readings are lower than those obtained under office conditions, and normal levels are below 135/85 mm Hg, not 140/90 mm Hg. The use of ABPM defines white coat HTN rather than home BPs, and the specific range of day-night variability does not guide specific drug therapy. ,


Clinical Presentation 35


A 9-year-old girl presents to the emergency department with acute onset of severe headache and a BP of 180/80 mm Hg. She is given 10 mg of sublingual nifedipine twice over 1 hour, with a reduction in pressure to 150/80 mm Hg. At this time, her only complaint is that she feels tired. Her physical examination is unremarkable other than a round face and short stature. An echocardiogram is normal.


Additional evaluation includes a renal ultrasound, urinalysis, blood urea nitrogen (BUN) and creatinine, plasma cortisol, and a 24-hour urine for metanephrines and catecholamines, all of which are within the normal range. Serum sodium is 142 mEq/L, potassium 3.1 mEq/L, chloride 92 mEq/L, and bicarbonate 29 mEq/L. A random urine chloride is 89 mEq/L. She is placed on 20 mg/day enalapril, 25 mg/day of hydrochlorothiazide, 10 mg/day of amlodipine, and 60 mEq of potassium daily. One month later, she presented with chest pain and a BP of 175/83 mm Hg.


Which one of the following laboratory tests would provide the greatest likelihood of making a correct diagnosis?




  • A.

    Renal angiogram


  • B.

    Peripheral plasma renin-to-aldosterone ratio


  • C.

    Dexamethasone suppression test


  • D.

    24-hour urinary aldosterone


  • E.

    Thyroid function studies



The correct answer is D


Comment: This patient has systolic HTN associated with hypokalemic metabolic alkalosis with normal renal function. Given the patient’s history and existing laboratory studies, the most likely diagnosis is either primary hyperaldosteronism or pseudo-hyperaldosteronism (Liddel syndrome). The most sensitive and specific test to rule out primary aldosteronism is a 24-hour urinary aldosterone level. Other tests, such as plasma renin or aldosterone, have many problems, and their value in this setting has not been validated.


Clinical Presentation 36


A 6-year-old girl presents with a BP of 194/116 mm Hg. Her baseline laboratory values include BMI of 23 kg/m 2 , glycated hemoglobin of 5%, microalbuminuria of 320 mg/g creatinine, serum creatinine of 1.0 mg/dL, BUN of 33 mg/dL, bicarbonate of 24 mEq/L, and potassium of 3.8 mEq/L. Urinalysis is otherwise normal. Echocardiogram shows left ventricular hypertrophy with no evidence for the coarctation of the aorta. She is receiving an ACEI, a CCB, and thiazide diuretic for BP management.


Which one of the following would be appropriate as a next step in her evaluation?




  • A.

    Perform renal ultrasound.


  • B.

    Order echocardiogram.


  • C.

    Measure urine microalbumin excretion.


  • D.

    Restrict sodium intake and add a loop diuretic.


  • E.

    Order magnetic resonance angiography to assess renal arteries.


  • F.

    Add clonidine.



The correct answer is E


Comment: This patient has severe hypertension. The clinical and laboratory findings suggest renal vascular hypertension. The best choice for a study would be a magnetic resonance angiography.


Clinical Presentation 37


A 17-year-old girl presents for a second opinion regarding her BP control and medicine regimen. She was told that she has renal insufficiency, but she feels fine. Her physical examination is unremarkable, and she currently receives an ACEI, thiazide diuretic, and nondihydropyridine calcium antagonist for her BP control. Her sitting BP is 146/84 mm Hg, with an abnormal pulse of 78. Laboratory tests demonstrate serum potassium of 3.5 mEq/L and serum creatinine of 1.4 mg/dL.


A 24-hour urine contains 108 mEq of sodium (adequate urine collection).


Which one of the following antihypertensive medications would help reduce mortality by inhibiting fibrosis of the heart and helping achieve her BP goal?




  • A.

    An ARB


  • B.

    A long-acting beta-blocker


  • C.

    An aldosterone receptor antagonist


  • D.

    Hydralazine


  • E.

    Clonidine



The correct answer is C


Comment: In this patient, low potassium is a clear contributor to persistent HTN. Potassium channels tend to close when hypokalemia is present, causing vasoconstriction that leads to a sustained elevation in BP. This patient needs potassium supplementation along with a potassium-sparing diuretic such as spironolactone.


Clinical Presentation 38


A 16-year-old White female presented to the emergency department with severe HTN and evidence of neurologic deficits. Her BP was 210/120 mm Hg, pulse was 88 beats/min, and she had a regular and continuous bruise over her left lateral abdominal area. Her serum creatinine level was 1.6 mg/dL, potassium 3.9 mEq/L, sodium 139 mEq/L, chloride 104 mEq/L, and bicarbonate 24 mEq/L. A chest x-ray was normal. She was given 10 mg of sublingual nifedipine and started on intravenous nitroprusside. She died suddenly in the process of being transferred to the intensive care unit.


Which of the following choices describes what should have been the best approach for this patient’s management?




  • A.

    Nothing different should have been done because she had a fatal cardiac arrhythmia.


  • B.

    Intravenous fenoldopam should have been substituted for nitroprusside because of her renal insufficiency.


  • C.

    Both intravenous labetalol and intravenous fenoldopam should have been given.


  • D.

    Intravenous nitroprusside and intravenous furosemide should have been administered.



The correct answer is C


Comment: It is clear from the physical examination that the patient has an abdominal aneurysm and renal insufficiency. Attempting to lower this patient’s pressure with vasodilators that will cause reflex tachycardia could result in further stress to the aortic wall and rupture the aneurysm, which is exactly what happened to this patient. The use of intravenous beta-blockers is ideal therapy in patients with a selective dopamine-1 receptor agonist to vasodilate without increasing heart rate.


Clinical Presentation 39


A 14-year-old boy with end-stage renal disease (ESRD) is dialyzed on the morning shift, at which his SBP is consistently between 150 to 170 mm Hg. After each treatment, his SBP remains above 140 mm Hg. A 24-hour BP monitor demonstrates that his average BP during the day is 148/72 mm Hg. At night, it averages 144/78 mm Hg.


He currently receives all his medications (ACEI, CCB, and beta-blocker) in the morning, but he does not take them on the morning of dialysis.


Which one of the following choices most accurately describes his cardiovascular risk?




  • A.

    He is at the same risk as the average ESRD patient.


  • B.

    He is at much higher risk than those ESRD patients whose BP manifests a nighttime dip.


  • C.

    His most likely time to have a cardiovascular event is in the late evening.


  • D.

    His prognosis will not improve if he converts to Dipper.


  • E.

    There is no known therapy that will convert him to dipping status.



The correct answer is B


Comment: Studies have shown that dialysis patients, like those non-dippers with normal renal function (i.e., those failing to decrease their normal SBP by at least 20 mm Hg), have a higher risk of CV events and death than do dippers.


Clinical Presentation 40


A 15-year-old girl with a BMI of 35 kg/m 2 and BP of 146/90 mm Hg is referred to you for new-onset microalbuminuria (59 mg/g creatinine; normal <20 mg/g). She has been on antihypertensive medications (50 mg/day of metoprolol) for the past 3 years. On this visit, you note all laboratory tests are normal except her fasting blood glucose of 124 mg/dL. Her current BP is 149/92 mm Hg and pulse is 68 and regular.


Which of the following is (are) the best management approach(es) for this patient?




  • A.

    Tell her to lose weight and put her on a 1200-calorie/day diet.


  • B.

    Increase metoprolol dose to achieve BP goal.


  • C.

    Add an ACEI to current medication.


  • D.

    Stop the beta-blocker and start an ACEI/diuretic and titrate to BP goal.



The correct answers are A and D


Comment: In addition to losing weight and modifications in lifestyle, based on her cardiovascular risk factor profile, the elevated BP, the ideal therapy for her would be an ACEI with a diuretic.


Clinical Presentation 41


A 13-year-old boy presents for a second opinion regarding difficulty in controlling his BP. He has taken an ACEI and an ARB at maximal doses but experienced only 8 to 10 mm Hg reduction in SBP. He is currently on maximal doses of a CCB and an ACEI with a sitting BP of 148/92 mm Hg.


Which one of the following genotypes might help predict an appropriate antihypertensive drug class to achieve the BP goal for this patient?




  • A.

    ACE gene


  • B.

    Angiotensinogen gene


  • C.

    Aldosterone synthase gene


  • D.

    Alpha-adducin gene


  • E.

    11-beta hydroxy steroid dehydrogenase gene



The correct answer is D


Comment: Adducin 1 ( ADD1 ) is a protein coding gene. Diseases associated with ADD1 include HTN and essential and esophageal atresia. Among its related pathways are activation of cAMP-dependent protein kinase A (PKA) and unfolded protein response. Gene ontology annotations related to this gene include RNA binding and protein heterodimerization activity. An important paralog of this gene is ADD3.


In an analysis of almost 1000 patients, it was noted that carriers of the adducin variant had a lower risk for CV events or stroke when they received diuretic therapy compared with other antihypertensive drugs. It was also noted that those with the adducin variant had greater reductions in BP in response to a diuretic compared with other therapies. , None of the other genotypes listed has been associated with this type of relationship to BP response and outcomes with a particular class of agents.


Clinical Presentation 42


A 15-year-old adolescent female presents to the emergency department with profound weakness and polyuria. Her past medical history is unremarkable. She is taking no medications. Family history is negative. Her temperature is 37°C, blood pressure 145/89 mm Hg, heart rate 84 beats/min, respiration rate 12 breaths/min, and BMI 25 kg/m 2 .


Serum sodium is 142 mEq/L, potassium 2.9 mEq/L, chloride 106 mEq/L, bicarbonate 29 mEq/L, BUN 12 mg/dL, and creatinine 0.5 mg/dL. Serum aldosterone is 2.2 ng/dL and plasma renin activity is less than 0.1 ng/mL/h.


Urinalysis shows a specific gravity of 1.025, pH 8, otherwise negative with unremarkable sediment. Random urinary potassium to creatinine is 2.1.


Generalized weakness and electrolyte abnormalities persisted despite treatment with large doses of oral potassium supplements and spironolactone.


Which of the following options at this point would best fit the patient’s conditions?




  • A.

    Obtain serum cortisol level.


  • B.

    Measurement of the ratio of cortisol to cortisone in a 24-hour urine


  • C.

    Measurement of urinary 17-hydroxysteroid


  • D.

    Measurement of serum Mg concentration


  • E.

    Switch spironolactone to amiloride.



The correct answer is E


Comment: Constellation of hypertension and hypokalemic metabolic alkalosis associated with decreased serum aldosterone and plasma renin activity, unresponsive to spironolactone, is strongly suggestive of Liddle syndrome.


An improvement in HTN and correction of hypokalemia and metabolic alkalosis is expected following amiloride administration (option E), , although genetic testing is the gold standard and can identify congenital defects.


Clinical Presentation 43


You are asked to see a 4-year-old with heart failure and reduced systolic ejection fraction from aortic. He has no edema. His blood pressure is 154/98 mm Hg.


Which of the following is the preferred choice for the management of hypertension in this patient?




  • A.

    ACEI or ARB in combination with a thiazide diuretic


  • B.

    ACEI or ARB in combination with CCB, spironolactone, and a low-sodium diet


  • C.

    ACE or ARB and spironolactone with a low-sodium diet


  • D.

    Labetalol and CCB in combination with a thiazide diuretic



The correct answer is C


Comment: Treatment of HTN in children with heart failure must be tailored, depending on the pathophysiology mechanism, status of systolic or diastolic function of the heart, severity of HTN, presence of end‐organ damage, and coexisting renal abnormalities.


Our patient presents with congestive heart failure associated with low cardiac output or reduced systolic ejection fraction. About half of the patients with CHF have systolic dysfunction and develop the classical symptoms of CHF, including edema. Systolic dysfunction is best treated with beta-blockers, ACEIs, ARB, and spironolactone plus a low-sodium diet (option C). A loop diuretic is recommended in the presence of edema.


For patients who have normal systolic fraction ejection with left ventricular hypertrophy or diastolic dysfunction, ACE or ARB and CCB tend to induce significantly more regression than beta-blockers.


Clinical Presentation 44


A 20-month-old girl with a history of polydipsia (more than 3 L/day), polyuria (more than 3 L/day), and weight loss (12–10.6 kg) that started 4 months ago, with an initial impression of Bartter syndrome, was transferred from another hospital. Laboratory blood tests performed at the previous hospital revealed metabolic alkalosis, hyponatremia, and hypokalemia with a high transtubular potassium gradient (TTKG). Her BP was measured to be 90/60 mm Hg initially. However, the BP checked on arrival at our hospital was as high as 190/120 mm Hg. Her height and weight were 86 cm (50th–75th percentile) and 11.07 kg (25th–50th percentile), respectively. Dehydrated lips and a large palpable abdominal mass were found on physical examination. There was no family history of inherited kidney diseases or hypertension.


Laboratory study results were as follows: serum sodium 131 mmol/L, potassium 2.9 mmol/L, chloride 92 mmol/L, osmolality 265 mOsm/kg, bicarbonate 28.4 mmol/L, blood pH 7.57, BUN 4 mg/dL, creatinine 0.23 mg/dL, and estimated GFR 154.25 mL/min/1.73 m 2 . She had proteinuria (urine protein/creatinine ratio 3.4 mg/mg) without hematuria or glucosuria. Urine electrolyte analysis showed diluted urine with osmolarity 157 mOsm/kg, sodium 27 mmol/L, chloride 32 mmol/L, and a TTKG of 5. Hormone studies for malignant hypertension revealed elevated plasma renin and aldosterone levels (renin 37 ng/mL/h, aldosterone 182 ng/dL), normal vanillylmandelic acid levels, and normal levels of plasma and urine catecholamines. Abdominal CT showed a large mass on the left kidney, encasing the left renal artery. Left ventricular hypertrophy was detected by echocardiography. A biopsy of the kidney mass revealed Wilms tumor and other imaging evaluations confirmed no evidence of metastasis.


Several antihypertensive medications failed to control hypertension. Hyponatremia and hypokalemia were transiently improved with intravenous fluid and oral electrolyte supplementation. After the left radical nephrectomy, BP and electrolyte imbalance were normalized, and no further medication was necessary.


What is the pathophysiology of this condition?




  • A.

    Apparent mineralocorticoid excess


  • B.

    Liddle syndrome


  • C.

    Hyperaldosteronism


  • D.

    Hyperactivation of the RAA system



The correct answer is D


Comment: The patient presented with polydipsia, polyuria, weight loss, and HTN. HTN was sufficiently severe in both cases to develop hypertensive cardiomyopathy and/or hypertensive retinopathy. Serum and urine laboratory tests revealed hyponatremia, hypokalemia with a high TTKG, hypochloremia, metabolic alkalosis, and proteinuria. Unilateral renal artery stenosis was found in imaging studies. Wilms tumor was the culprit of this case. This condition is known as hyponatremic-hypertensive syndrome.


Hyperactivation of the RAA axis is regarded to be the key pathophysiologic mechanism behind specific symptoms and electrolyte imbalances in hyponatremic-hypertensive syndrome. If unilateral RAS is severe enough to induce renal ischemia in the affected kidney, the ischemic kidney secretes a large amount of renin, which leads to increased levels of Ang II, a potent vasoconstrictor. Arterial pressure rises, and hyperfiltration in the contralateral kidney results in hyponatremia and volume depletion, known as pressure natriuresis. Increased aldosterone levels, another effect of Ang II, lead to hypokalemia. Both Ang II and volume depletion stimulate antidiuretic hormone secretion, which is responsible for thirst and polydipsia, further worsening hyponatremia. Proteinuria is a result of glomerular hyperfiltration and the proteinuric effect of Ang II.


Clinical Presentation 45


A 15-year-old girl with no significant past medical history presented for evaluation of a left neck mass. The mass had been growing for approximately 1 year. Contrast-enhanced CT of the neck showed a well-circumscribed cystic mass originating from the left carotid space extending into the left parotid space, with associated mass effect and near-complete effacement of the upper internal jugular vein. She was scheduled for surgical excision of the mass; however, while in the preoperative anesthesia care unit, she became hypertensive to 170/110 mm Hg. She remained hypertensive even after receiving midazolam for induction of anesthesia, so surgical excision of the mass was postponed.


Serum electrolytes, urea, creatinine, calcium, and uric acid concentrations were normal. Urinalysis showed specific gravity 10.17, pH 6.0 no blood or protein.


After recovery from anesthesia, she was alert, talkative, and in no acute distress. She had normal pupils that were reactive to light. Her left parotid area was notable for a firm 4-cm immobile mass, deep to the left earlobe and outwardly displacing the ear. There was neither significant tenderness nor lymphadenopathy, and there were no carotid bruits. Her laboratory results were unremarkable. The patient was admitted to the nephrology service for further evaluation and management. A transthoracic echocardiogram and Doppler ultrasound of the kidney and bladder were normal. MRI of the neck redemonstrated a well-defined, highly vascular mass, centered in the left parotid space with mass effect on the left internal jugular vein and parotid gland.


Further history revealed that at an outpatient visit 3 weeks prior, the patient’s systolic BP was elevated to 160 mm Hg, and she had a previous emergency room visit for dizziness, nausea, and abdominal pain where her BP was 130/80 mm Hg. She also endorsed daily frontal headaches for the past few months, associated with phonophobia and resolving with acetaminophen. Her last headache was on the day before admission.


What is the likely cause of hypertension in this patient?




  • A.

    Mineralocorticoid excess renal artery stenosis and renal parenchymal disease


  • B.

    Coarctation of the aorta


  • C.

    Renal artery stenosis


  • D.

    Pheochromocytoma



The correct answer is D


Comment: In this patient with a parotid mass, headaches, and episodic hypertension, considerations include catecholamine-secreting tumors as well as a mass effect on the sympathetic ganglion or vascular supply resulting in compensatory hypertension to maintain cerebral perfusion. Plasma metanephrines were sent and a 24-hour urine collection for catecholamines was started. The results of her plasma and urinary metanephrines confirmed a catecholamine-secreting tumor. She underwent a subsequent positron emission tomography Ga68-DOTATE scan, which showed that her neck mass, along with multiple lesions in the chest and abdomen, were all somatostatin-receptor-rich, consistent with a metastatic catecholamine-secreting paraganglioma.


Pheochromocytomas and paragangliomas are rare tumors that are seen in approximately 2% of children who present with hypertension. A patient with a pheochromocytoma and paraganglioma typically presents with intermittent, recurrent symptoms of catecholamine excess, such as hypertension, headaches, or diaphoresis. Other, less specific symptoms include anxiety and panic attacks, as well as nausea, vomiting, and tremors. Although most patients will present with hypertension and headaches, up to 25% of cases will be entirely asymptomatic. ,


Pheochromocytomas and paragangliomas can be diagnosed with blood tests and imaging. The most sensitive biochemical tests are plasma-free metanephrines and normetanephrine, the breakdown products of catecholamines, which have a sensitivity of up to 100% in children. Urinary metanephrines can be used in equivocal cases, with sensitivities that are similarly high in many studies. If biochemical testing shows elevated levels of catecholamines, contrast-enhanced CT of the abdomen, specifically protocolized to the adrenal gland, is a reasonable first imaging study. This can be followed by MRI, which is more sensitive for the detection of extraadrenal masses. If neither of these studies visualizes any masses despite biochemical evidence of disease, functional iodine-123 metaiodobenzylguanidine scintigraphy can be considered. Alternatively, positron emission tomography with fluorine-18-labeled dihydroxyphenylalanine may offer better sensitivity than metaiodobenzylguanidine because of better visualization of anatomy and less radiographic artifact and is preferred in patients with metastatic disease.


Clinical Presentation 46


A 19-year-old man was admitted for elective surgery for resection of a brain mass resulting from metastatic melanoma. He had a history of prostate cancer treated with resection 6 years ago and resection of a small-bowel carcinoid tumor that had recurred with peritoneal nodules. Nephrology was consulted for the evaluation of persistent hypokalemia and metabolic alkalosis. The patient denied abdominal pain, headache, fever, vomiting, or diarrhea. He did not use over-the-counter or herbal medications. Home medications included omeprazole 20 mg and daily and monthly octreotide injections. In the hospital, he was receiving omeprazole 20 mg daily; levetiracetam 1000 mg twice per day for seizure prophylaxis after his brain surgery; and subcutaneous heparin 5000 units twice per day for deep venous thrombosis prophylaxis. On physical examination, the patient’s temperature was 37.3°C (99.1°F), heart rate was 90 beats/min, BP was 155/95 mm Hg, respiration rate was 14 breaths/min, and oxygen saturation was 97% on room air. Cardiac examination findings were unremarkable. Lungs were clear bilaterally. His abdomen was soft with no visceromegaly or tenderness. There was no edema. There were no focal neurologic findings.


Laboratory investigation showed sodium 144 mEq/L, potassium 2.8 mEq/L, chloride 99 mEq/L, bicarbonate 33 mEq/L, urea nitrogen 18 mg/dL, creatinine 0.8 mg/dL, calcium 7.9 mg/dL 7.9, albumin 3.8 g/dL, glucose 95 mg/dL Additional studies included arterial blood gas pH 7.52 PCO 2 38 mm Hg, PO 2 90 mm Hg, and HCO 3 32 mEq/L. Urine potassium (random) 104 mEq/L, urine chloride (random) 60 mEq/L. Plasma renin 0.6 ng/m (normal, 1.06 (range 0.25–5.82)), plasma aldosterone 1 ng/dL (normal, 3–16), plasma cortisol (morning) 41 mcg/dL (normal, 6–26), 24-hour urine cortisol 1062 (normal, 4–50 24-hours), urine creatinine 1.1 g/24 hours (0.63–2.50), Plasma corticotropin 92 pg/mL (normal, 92 (range 6–50)).


What is the most likely cause of this patient’s hypokalemia, metabolic alkalosis, and hypertension?




  • A.

    Liddle syndrome


  • B.

    Syndrome of apparent mineralocorticoid excess


  • C.

    Congenital adrenal hyperplasia


  • D.

    Cushing syndrome



The correct answer is D


Comment: Hypokalemia is generally due to either urinary or gastrointestinal tract losses, a shift from the extracellular to intracellular fluid compartment, or in rare cases, decreased oral intake. In our patient, renal losses were thought to be most likely given the elevated urinary potassium concentration.


Metabolic alkalosis is often classified as chloride responsive (urine chloride <20 mEq/L) or chloride resistant (urine chloride >20 mEq/L). When urine chloride excretion is <20 mEq/L, the metabolic alkalosis is usually saline responsive. In metabolic alkalosis, urine chloride concentration may be a more accurate indicator of intravascular volume depletion than urine sodium concentration because bicarbonaturia in early stages of development of a chloride-depletion metabolic alkalosis results in sodium and potassium excretion in urine (as accompanying cations with bicarbonate). Thus, urine sodium and potassium concentrations may be elevated in the first 24 to 72 hours of volume depletion, then decline subsequently. Urine chloride concentration will remain low because of ongoing sodium and chloride reabsorption in the proximal tubule from activation of the RAA axis and other factors in response to volume depletion.


Our patient developed chloride-resistant metabolic alkalosis (urine chloride >20 mEq/L). Given the presence of hypertension along with urine potassium excretion >20 mEq/L and low levels of both serum renin and aldosterone, the differential diagnosis includes Liddle syndrome, syndrome of apparent mineralocorticoid excess, Cushing syndrome, congenital adrenal hyperplasia, and excessive licorice use.


Given the patient’s elevated morning cortisol level, markedly increased 24-hour urine cortisol excretion, and high serum corticotropin (ACTH) level, ACTH-dependent Cushing syndrome was diagnosed. ,


ACTH-dependent Cushing syndrome could result from either an ACTH-secreting pituitary tumor or an ectopic ACTH-secreting tumor. Findings from MRI of the pituitary gland and CT of the chest were unremarkable. CT of the abdomen revealed peritoneal nodules consistent with his history of recurrent carcinoid tumor. Ectopic ACTH-dependent Cushing syndrome, most likely from the active carcinoid tumor, was diagnosed. There are few case reports that describe Cushing syndrome attributed to the presence of carcinoid tumor. 3 What are treatment options for this patient? Cortisol has the capacity to bind mineralocorticoid receptors in principal cells of the cortical collecting duct. Normally, this is limited by conversion of cortisol to cortisone, which is unable to bind to the mineralocorticoid receptor, by the enzyme 11 hydroxysteroid dehydrogenase type 2. Excess production of cortisol, as in our patient, saturates the enzyme, allowing cortisol to persist and activate mineralocorticoid receptors. This causes translocation of epithelial sodium channel proteins into the luminal membrane, increasing basolateral adenosine triphosphatase sodium/potassium pump activity and increasing renal outer medullary potassium channel activity, leading to sodium reabsorption and hypertension, hypokalemia, and metabolic alkalosis.


Clinical Presentation 47


A 14-year-old female with no significant medical or familial history was evaluated for 1 week of intermittent bouts of mild flank pain, occasionally associated with nausea and vomiting. The patient denied fever, chills, or hematuria. On physical examination, BP was 150/100 mm Hg and bilateral flank fullness and tenderness were noted. Laboratory tests showed serum creatinine level of 0.85 mg/dL, corresponding to estimated GFR of 65 mL/min/1.73 m 2 . Urinalysis showed hematuria (+), white blood cells (+), and proteinuria (++). Microscopic examination of urine sediment showed three to five white blood cells/high-power field, five to nine red blood cells/high-power field, scattered dysmorphic red blood cells, tubular epithelial cells, and fatty casts. A 24-hour urinary protein measurement was 0.9 g, up from 0.5 g 1 year earlier. Abdominal ultrasound showed enlarged kidneys (left measuring 12.2 cm; right, 13.51 cm) with abnormal appearance. A CT showed bilateral kidney parenchymal thinning with peripelvic and perirenal fluid attenuation collections. These lesions could not be enhanced with contrast. Scalloping of both kidneys also was noted. Magnetic resonance urography showed multiloculated cysts and fibrous septae within both kidneys, with the lesions giving high signal intensity on the T2-weighted image.


What is the clinical pathologic diagnosis?




  • A.

    Renal lymphangiectasia


  • B.

    Polycystic kidney disease


  • C.

    Multicystic renal tumor


  • D.

    Medullary sponge kidney



The correct answer is A


Comment: Based on clinical features and imaging findings, a diagnosis of renal lymphangiectasia was made. Needle aspiration of the perinephric fluid was performed, with laboratory analysis showing a predominance of lymphocytes. The differential diagnosis must include polycystic kidney disease as well as cystic renal tumors (especially multilocular cystic renal tumors). Polycystic kidney disease commonly has a familial history, with multiple cysts arising from the renal parenchyma and often within the liver. Most cystic kidney tumor lesions are solitary and arise from renal parenchyma with solid content in contrast CT. In uncertain cases, fine-needle biopsy is useful to establish the diagnosis.


Renal lymphangiectasia is a rare benign disorder of lymphatic malformation characterized by disruption of the perirenal lymphatic system. The renal capsule lymphatics and perinephric tissue empty into the renal sinus lymphatics, which drain into the para-aortic, paracaval, and interaortic nodes. The lymph then flows through the lumbar trunk and thoracic duct before emptying into the left brachiocephalic vein, superior vena cava, and right heart. Renal sinus drainage disturbances lead to an ectatic perirenal, peripelvic, and intrarenal lymphatic system, which explains the classic imaging findings. Clinically, renal lymphangiectasia can be detected incidentally by ultrasonography or CT in patients who undergo abdominal imaging procedures. The most common concerns are flank pain and abdominal distension, but hematuria, proteinuria, cyst hemorrhage, hypertension, fever, and, rarely, decreased kidney function can develop. On occasion, renal lymphangiectasia can present with infection and bleeding that result in acute pain. The clinical evolution and prognosis of renal lymphangiectasia are unclear. Owing to the rarity of the condition, no standard treatment is established. Asymptomatic and localized cases can be managed conservatively because the condition does not affect kidney function. If kidney function decreases or collections become symptomatic, percutaneous drainage can relieve compression. Recurrent collections may require marsupialization into the peritoneum. In severe uncontrollable cases, nephrectomy may be performed. Our patient’s perinephric collections were large and resulted in discomfort, so percutaneous drainage was performed to relieve compression and protect kidney function. After 1 month, drainage decreased to 5 mL per day and the tubes were removed. No fluid reaccumulation appeared during 6 months of follow-up.


Clinical Presentation 48


A 19-year-old woman presented with HTN. Two years earlier, she had been evaluated for elevated BP of 150–170/110–120 mm Hg and found to have a serum potassium level of 2.6 mmol/L and plasma renin concentration of 362 mIU/L (reference range, 2.8–40 mIU/L) in the supine position. She underwent renal angiography, for which there were no findings of note. The patient was prescribed amlodipine 5 mg and irbesartan 150 mg/d, and her BP responded promptly by decreasing to 115/70 mm Hg. On presentation, the patient denied symptoms aside from nocturia. She had no headache, chest pain, or edema. Her family history was not notable for any diseases or syndromes. She was not taking antihypertensive medication, and BP was 156/110 mm Hg. The rest of her examination findings were unremarkable, and she had no apparent obesity. She had a serum potassium level of 3.0 mmol/L, serum bicarbonate level of 23 mmol/L, serum creatinine level of 0.64 mg/dL (57 mmol/L; corresponding to eGFR 90 mL/min/1.73 m 2 ), and spot urine albumin-creatinine ratio of 42 mg/mmol. Plasma renin concentration was 846 mIU/L (reference range, 2.8–40 mIU/L) in the supine position, and serum aldosterone level was 2370 pmol/L (reference range, 30–444 pmol/L) in the supine position.


What is (are) the cause(s) of hypertension in this patient?




  • A.

    Cushingoid syndrome


  • B.

    Juxtaglomerular cell tumor


  • C.

    Primary hyperaldosteronism


  • D.

    Apparent mineralocorticoid excess



The correct answer A


Comment: The most common causes of hypertension in young women are essential hypertension or hypertension as part of metabolic syndrome. Secondary causes include fibromuscular dysplasia, overproduction of aldosterone, and hormonal causes such as those related to oral contraceptive use or pregnancy-induced hypertension. In this age group, additional endocrine explanations for secondary hypertension include thyroid or parathyroid disorders and low vitamin D levels. A rare but important cause is coarctation of the aorta. Finally, exogenous factors such as licorice consumption, substantial alcohol intake, and use of nonsteroidal antiinflammatory drugs should be investigated and/or ruled out.


In the present case, the patient was pregnant, but hypertension in gestational week 7 should not be regarded as gestational hypertension or preeclampsia.


Renin is produced by juxtaglomerular cells in the kidney and plays a major role in BP regulation by inducing the RAA system. Hypertensive high renin states can be secondary or primary. Secondary causes of a high renin state include renovascular disease, most commonly fibromuscular dysplasia of the renal artery in young women. Additionally, hypertensive states per se are associated with a slight increase in renin levels, but this is much more pronounced in the malignant hypertensive condition. This might be explained by renovascular ischemia resulting from intimal hyperplasia. As for primary causes of hypertensive high renin states, renin-producing renal tumors can be seen with simultaneous high aldosterone levels. Duplex ultrasound examination of the kidneys and echocardiography were performed to exclude renal artery stenosis and coarctation of the aorta. Magnetic resonance tomography of the upper abdomen identified a mass in the caudal area of the left kidney. Plasma renin and aldosterone concentrations in the left renal vein were 1230 mIU/L and 3900 pmol/L, respectively. In a peripheral vein, values were 726 mIU/L and 1330 pmol/L, respectively.


This high secretion of renin from the left tumor-containing kidney supports the diagnosis of reninoma.


111 In-octreotide scintigraphy was performed, showing high uptake of the radionuclide in the left renal mass. This uptake is due to the high expression of somatostatin receptor type 2 (SSTR2) by tumor cell. This was further supported by immunohistochemical analysis of the surgical specimen, which demonstrated strong membranous staining of tumor cells by a monoclonal anti-SSTR2 antibody. Most reninomas are benign, but metastatic cases have been reported. The patient underwent surgical resection of the tumor with normalization of BP (110/70 mm Hg without medication) and renin and aldosterone levels (18.0 mU/L and 232 pmol/L, respectively). Because the tumor was clearly visible on 111 In-octreotide scintigraphy and expressed SSTR on immunohistochemical staining, a neuroendocrine phenotype for the tumor was identified. This suggests the opportunity to control hormone secretion and tumor cell proliferation in these tumors by long-acting somatostatin analogues or targeted radiotherapy in the case of unresectable masses. , The final diagnosis was hypertension from a juxtaglomerular cell tumor (reninoma) secreting large amounts of renin.



References

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Feb 15, 2025 | Posted by in NEPHROLOGY | Comments Off on Hypertension

Full access? Get Clinical Tree

Get Clinical Tree app for offline access